Detailed Program
- Current Page
- Program > Detailed Program
English Session
Korean SessionHeart Failure with Preserved EF: Diverse Phenotypes & Treatment Strategies
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | KOR Heart Failure with Preserved EF: Diverse Phenotypes & Treatment Strategies |
Wook-Jin Chung (Gachon Univ., Korea)
, Seong-Mi Park (Korea Univ., Korea) |
||
| 박출률 보존 심부전의 표현형을 이해하고, 각 임상 표현형과 동반질환에 따른 환자 예후에 미치는 영향을 안다. | ||||
| 박출률 보존 심부전의 대표적 임상 표현형 및 동반질환에 따른 (Obesity, AF, Microvascular angina, LA Dysfunction) 특징을 공부하고 각각의 임상 경과에 미치는 영향과 개별 환자에 최적화된 치료법을 논의하고자 한다. | ||||
| 09:00-09:15 | The Weight of Heart Failure: How Obesity Shapes HFpEF |
|
Dong-Hyuk Cho (Korea Univ., Korea) | |
| 09:15-09:30 | Left Atrial Function in Heart Failure |
|
Chi Young Shim (Yonsei Univ., Korea) | |
| 09:30-09:45 | Atrial Fibrillation: Fueling the Fire in HFpEF |
|
Mi-Na Kim (Korea Univ., Korea) | |
| 09:45-10:00 | Microvascular Angina in HFpEF: Unveiling the Hidden Threat |
|
Joo Myung Lee (Sungkyunkwan Univ., Korea) | |
| 10:00-10:20 | Discussion |
Sung Hea Kim (Konkuk Univ., Korea) , Jihun Jang (Inha Univ., Korea) , Hyeonju Jeong (Myongji Hospital, Korea) , Uram Jin (Ajou Univ., Korea) |
||
Morning Session 1 
Hypertension: What's New in Diagnosis and Treatment?
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room A | ||||
| 08:00-09:00 |
KOR
Morning Session 1 Hypertension: What's New in Diagnosis and Treatment? |
Seonghoon Choi (Hallym Univ., Korea) | ||
| 08:00-08:30 | Approaches for the Medical Management of Resistant Hypertension | Chan Joo Lee (Yonsei Univ., Korea) | ||
| 08:30-09:00 | Why You Need to Include Night-BP as Part of Routine Hypertension Diagnosis Protocol | Jung Woo Son (Yonsei Wonju Univ., Korea) | ||
Morning Session 3 
Kerendia®: Taking Heart Health Possibilities Further
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Room A | ||||
| 08:00-08:40 |
KOR
Morning Session 3 Kerendia®: Taking Heart Health Possibilities Further |
Myeong-Chan Cho (Chungbuk National Univ., Korea) | ||
| 08:00-08:20 | Exploring Kerendia®: Understanding the Mechanism and Real-World Use | Minjae Yoon (Seoul National Univ., Korea) | ||
| 08:20-08:40 | Value of Kerendia®: Clinical Trial Results and Subgroup Analyses in Heart Failure | Dong-Hyuk Cho (Korea Univ., Korea) | ||
Tricuspid Regurgitation and Heart Failure: An Intimate Relationship
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 10:30-11:50 | KOR&ENG Tricuspid Regurgitation and Heart Failure: An Intimate Relationship |
Jae-Joong Kim (Ulsan Univ., Korea)
, Geu-Ru Hong (Yonsei Univ., Korea) |
||
| A review and discussion of current updates in the diagnosis and treatment of tricuspid regurgitation. | ||||
| To comprehensively understand the various mechanisms, clinical implications, and current management strategies for tricuspid regurgitation, including device-related TR, TR in transplant or mechanically supported hearts, functional TR in HFpEF, and recent interventional treatments. | ||||
| 10:30-10:45 | Functional TR in Heart Failure with Preserved EF: Risk Factors and Management |
|
Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan) | |
| 10:45-11:00 | CIED-related TR and Heart Failure: Challenges and Solutions |
|
Jiwon Seo (Yonsei Univ., Korea) | |
| 11:00-11:15 | Etiology and Implications of TR in Patients with Transplant Heart or Mechanical Support |
|
Kyung-Hee Kim (Incheon Sejong Hospital, Korea) | |
| 11:15-11:30 | Recent Updates on Interventional Treatment of Functional TR |
|
Sung-Ji Park (Sungkyunkwan Univ., Korea) | |
| 11:30-11:50 | Discussion |
Kyung-Jin Kim (Ewha Womans Univ., Korea) , Dae-Young Kim (Inha Univ., Korea) , Se Eun Kim (Yonsei Wonju Univ., Korea) |
||
[Joint Session with KTCVS] Recent Updates in Surgical Treatments for Heart Failure
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | KOR [Joint Session with KTCVS] Recent Updates in Surgical Treatments for Heart Failure |
Mi-Seung Shin (Gachon Univ., Korea)
, Young-Nam Youn (Yonsei Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
| 심부전환자에서 수술적 치료가 필요한 상황과 위험-이득에 대해 심부전 전문가의 강의를 듣고, Surgeon들에게 각 수술에 대해 수술 영상과 함께 경험한다. | ||||
| 심부전 환자에서 적용되는 수술적 치료 방법이 많이 발전하였고, 수술 시간도 짧아졌지만, 막연한 두려움이 있다. 대한심장혈관흉부외과 학회에서 초청한 외과 교수님들의 실제 수술 경험과 발전을 들을 수 있는 세션이다. | ||||
| 09:00-09:15 | Evaluating Risks and Benefits of Surgical Treatments in HF Patients |
|
Hyung Yoon Kim (Incheon Sejong Hospital, Korea) | |
| 09:15-09:30 | Surgical Treatment for Functional Tricuspid Regurgitation: What's New? [with VIDEO] |
|
Jae Suk Yoo (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 09:30-09:45 | AF Surgery and LAA Clipping: To Whom, How To? [with VIDEO] |
|
Hyunggon Je (Seoul National Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 09:45-10:00 | Surgical Challenges during and after VAD [with VIDEO] |
|
Yu Rim Shin (Yonsei Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 10:00-10:20 | Discussion |
Jihoon Kim (Hallym Univ., Thoracic and Cardiovascular Surgery, Korea) , Dong Ryeol Ryu (Kangwon National Univ., Korea) , Dae-Hwan Bae (Bucheon Sejong Hospital, Korea) , Jiwon Seo (Yonsei Univ., Korea) |
||
[Joint Session with KSIC] Interventional Treatment of HF vs. HF Treatment after Intervention
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 08:40-10:00 | KOR [Joint Session with KSIC] Interventional Treatment of HF vs. HF Treatment after Intervention |
Choong-Won Goh (Ewha Womans Univ., Korea)
, Youngkeun Ahn (Chonnam National Univ., Korea) |
||
| 심부전 환자에서 관상동맥 중재술, 구조심질환에 대한 시술의 효용성과 적용을 안다. | ||||
| 대한심혈관중재학회와의 조인트세션으로 심부전의 원인이 되는 관상동맥질환, 구조심질환에 대한 심부전 전문가와 인터벤션 전문가의 의견을 각각 공유하고 토론한다. | ||||
| 08:40-08:55 | Useful or Useless Coronary Intervention in Heart Failure: Interventionist's Perspectives |
|
Joo Myung Lee (Sungkyunkwan Univ., Korea) | |
| 08:55-09:10 | GDMT for Heart Failure in Ischemic Heart Disease: HF Specialist's Perspectives |
|
Seonghoon Choi (Hallym Univ., Korea) | |
| 09:10-09:25 | Useful or Useless Structural Heart Intervention in Heart Failure: Interventionist's Perspectives |
|
Ha-Wook Park (Bucheon Sejong Hospital, Korea) | |
| 09:25-09:40 | GDMT Before and After Structural Heart Intervention: HF Specialist's Perspectives |
|
Sung-Ji Park (Sungkyunkwan Univ., Korea) | |
| 09:40-10:00 | Discussion |
Hyuck-Jun Yoon (Keimyung Univ., Korea) , Sung Woo Cho (Inje Univ., Korea) , Seon-Ah Jin (Chungnam National Univ., Korea) |
||
Opening Ceremony
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
| Room A | ||||
| 12:10-12:40 | ENG Opening Ceremony | |||
[Joint Session with KSE] Hemodynamics Assessment and Imaging for HF
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | KOR [Joint Session with KSE] Hemodynamics Assessment and Imaging for HF |
Dae-Gyun Park (Hallym Univ., Korea)
, Haeok Jung (The Catholic Univ., Korea) |
||
| POCUS부터 비침습적, 침습적 혈역학적 평가까지 심초음파검사를 통해서 얻어진 정보를 해석하고 Hemodynamics는 이해하여 심부전환자의 진단과 치료에 실제적인 도움이 되었으면 한다. | ||||
| 심부전환자의 진단과 위험도 평가에 빠질 수 없는 심장초음파를 이용한 진단과 혈역학적 평가에 대해서 다양한 임상상황에서 이해하고 적용해 본다. | ||||
| 10:40-10:55 | Point of Care Ultrasound for HF Patients in Emergency Department |
|
Kang-Un Choi (Yeungnam Univ., Korea) | |
| 10:55-11:10 | Bedside Echocardiography in Critically Ill Patients: What Should We Evaluate? |
|
Jung Hyun Choi (Pusan National Univ., Korea) | |
| 11:10-11:25 | Clinical Application of Left Atrial Strain and Invasive LA Hemodynamics |
|
Jihoon Kim (Sungkyunkwan Univ., Korea) | |
| 11:25-11:40 | Assessment of Right Ventricle and Pulmonary Hemodynamics: Make It Simple |
|
Seo-Yeon Gwak (Korea Univ., Korea) | |
| 11:40-12:00 | Discussion |
Jino Park (Inje Univ., Korea) , Jin Wi (Gachon Univ., Korea) , Nuri Lee (Chonnam National Univ., Korea) , Kyeong-Hyeon Chun (Yonsei Univ., Korea) |
||
[Heart Failure Precision Medicine and Genomic Research Association] Genetics - Basic to Clinical Practice
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 10:20-11:40 | KOR [Heart Failure Precision Medicine and Genomic Research Association] Genetics - Basic to Clinical Practice |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Jin-Ok Jeong (Chungnam National Univ., Korea) |
||
| 심부전에서의 정밀의료에 대한 기본과 실제 적용에 대하여 이해한다. | ||||
| 임상 실무에서 점차 증가하는 유전자 검사와 개인 맞춤의학의 필요성에 따라, 이 세션을 통해 기초적인 유전 개념부터 약물 유전학, 유전상담의 실제적 적용법과 다유전자 위험 점수(polygenic risk score)의 활용까지 체계적으로 습득함으로써 의료진이 환자 진료에 있어 유전자 정보를 효과적으로 활용할 수 있도록 돕는 것을 목표로 한다. | ||||
| 10:20-10:35 | Genetics and Genomics 101: Pedigrees, Penetrance, and Purgatory |
|
Jaewon Oh (Yonsei Univ., Korea) | |
| 10:35-10:50 | How to Interpret Genetic Test Results in Cardiomyopathies |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 10:50-11:05 | Cardio-Genetic Counseling: What Do You and Your Patients Need to Know Before and After the Genetic Test |
|
Jin-hee Lee (Asan Medical Center, Korea) | |
| 11:05-11:20 | Interpretation and Utilization of Polygenic Risk Scores in Your Practice |
|
Tae-Min Rhee (Seoul National Univ., Korea) | |
| 11:20-11:40 | Discussion |
Bo Eun Park (Kyungpook National Univ., Korea) , Moon-Seung Soh (Ajou Univ., Korea) , Mi-Hyang Jung (The Catholic Univ., Korea) , David Hong (Sungkyunkwan Univ., Korea) |
||
Luncheon Session 1 
Empagliflozin in Chronic Heart Failure: Evidence Across Ejection Fractions
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
| Room A | ||||
| 12:40-13:40 |
KOR
Luncheon Session 1 Empagliflozin in Chronic Heart Failure: Evidence Across Ejection Fractions |
Eung Ju Kim (Korea Univ., Korea) | ||
| 12:40-13:05 | Translating Evidence into Practice: Optimizing HFpEF Management with Empagliflozin | Hyo-In Choi (Sungkyunkwan Univ., Korea) | ||
| 13:05-13:30 | Empagliflozin in Action: Enhancing GDMT Strategies for HFrEF | Jin Joo Park (Seoul National Univ., Korea) | ||
| 13:30-13:40 | Discussion | |||
Luncheon Session 4 
Advancing Quality in Heart Failure: Entresto at the Core
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room A | ||||
| 12:00-13:00 |
ENG
Luncheon Session 4 Advancing Quality in Heart Failure: Entresto at the Core |
Byung-Hee Oh (Incheon Sejong Hospital, Korea) | ||
| 12:00-13:00 | The Myth of the “Stable” Heart Failure Patient: ARNI and the Risks of Omission | Stephen Greene (Duke Univ., USA) | ||
Luncheon Session 7 
Common but Not Simple: Anticoagulation Therapy in Atrial Fibrillation Patients with Comorbidities
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Room A | ||||
| 12:20-13:20 |
KOR
Luncheon Session 7 Common but Not Simple: Anticoagulation Therapy in Atrial Fibrillation Patients with Comorbidities |
Sang-Hong Baek (The Catholic Univ., Korea)
, Chi Young Shim (Yonsei Univ., Korea) |
||
| 12:20-12:45 | EP Specialist - Case Review : Managing AF in Frail and Elderly Patients | So-Ryoung Lee (Seoul National Univ., Korea) | ||
| 12:45-13:10 | HF Specialist - Case Review : Improving Adherence in Patients with Atrial Fibrillation | Jiwon Seo (Yonsei Univ., Korea) | ||
| 13:10-13:20 | Discussion | |||
[Digital Health Council] The Future of HF Management with Digital Health
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 13:40-15:00 | KOR [Digital Health Council] The Future of HF Management with Digital Health |
Dong-Ju Choi (Seoul National Univ., Korea)
, Eung Ju Kim (Korea Univ., Korea) |
||
| 인공지능을 활용한 디지털헬스연구회의 최신 연구 동향과 심부전 진단과 치료에의 실제 활용을 배운다. | ||||
| 최근 발전하는 생성형 AI 및 의료용 AI의 기능과 활용, 효용성에 대해서 알아보고 그 적용에 대하여 구체적으로 공부해보고자 한다. | ||||
| 13:40-13:55 | Applications of ChatGPT, Claude, and Gemini |
|
Sunki Lee (Korea Univ., Korea) | |
| 13:55-14:10 | The Evolution of Medical AI: Current Landscape and Future Directions |
|
Dong-Ju Choi (Seoul National Univ., Korea) | |
| 14:10-14:25 | AI Voice and Face Analysis for CV Disease Prediction |
|
Eung Ju Kim (Korea Univ., Korea) | |
| 14:25-14:40 | The Role of AI in Coronary Angiography |
|
Si-Hyuck Kang (Seoul National Univ., Korea) | |
| 14:40-15:00 | Discussion |
Ju-Hee Lee (Chungbuk National Univ., Korea) , Sang-Ho Jo (Hallym Univ., Korea) , Youngjin Cho (Seoul National Univ., Korea) , Seonghoon Choi (Hallym Univ., Korea) |
||
[Joint Session with KCSWG] Cardiogenic Shock - Expanding the Horizons of MCS
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | KOR [Joint Session with KCSWG] Cardiogenic Shock - Expanding the Horizons of MCS |
Min-Seok Kim (Ulsan Univ., Korea)
, Jeong Hoon Yang (Sungkyunkwan Univ., Korea) |
||
| 심인성쇼크 치료에 쓸 수 있는 다양한 기계순환보조(MCS) 장비들의 특성과 활용 방안에 대해 파악한다. | ||||
| 대한심인성쇼크 연구회와의 조인트 세션으로 심인성쇼크에서 MCS의 적용 현황과 다양한 MCS 장치들의 사용 전망에 대해 내과와 외과가 만나 같이 토론한다. | ||||
| 13:00-13:15 | Current Status and Outcomes of MCS in Cardiogenic Shock in Korea: Insights from Registry Data |
|
Ki Hong Choi (Sungkyunkwan Univ., Korea) | |
| 13:15-13:30 | Left Heart Venting in VA ECMO: Armamentarium of Techniques and Approaches |
|
Jae Seung Jung (Korea Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 13:30-13:45 | Impella Heart Pumps: Current Status, Clinical Impact, and Domestic Introduction |
|
Hyun-Jai Cho (Seoul National Univ., Korea) | |
| 13:45-14:00 | CentriMag: Overview, Clinical Applications, and Initial Experience in Korea |
|
Seunghwan Song (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 14:00-14:20 | Discussion |
Dae-Hwan Bae (Bucheon Sejong Hospital, Korea) , Seung Hun Lee (Chonnam National Univ., Korea) , Hee Jeong Lee (Keimyung Univ., Korea) , Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
[Educational Session for Allied Professionals, Nurses, and Trainees] Acute HF Patients from Admission to Discharge
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 13:20-14:40 | KOR [Educational Session for Allied Professionals, Nurses, and Trainees] Acute HF Patients from Admission to Discharge |
Dong-Ho Shin (Yonsei Univ. Geriatrics, Korea)
, Ju-Hee Lee (Chungbuk National Univ., Korea) |
||
| 급성 심부전으로 입원한 환자를 이해한다. | ||||
| 급성 심부전으로 입원한 환자를 간호하는데 필요한 지식과 실제 임상 상황에서의 대처법을 공부한다. | ||||
| 13:20-13:35 | Diagnosis and Acute Management of Heart Failure in ER |
|
Je Seop Lee (Inha Univ., Emergency Medicine, Korea) | |
| 13:35-13:50 | Detection and Rapid Response: Team Activation in Aggravating Heart Failure |
|
Sang Wook Park (Yonsei Wonju Univ., Integrated Medicine, Korea) | |
| 13:50-14:05 | How to Monitor: Which Monitoring Method Do You Prefer? |
|
Soo Yong Lee (Pusan National Univ., Korea) | |
| 14:05-14:20 | Decongestion: from Diuretics to Ultrafiltration |
|
Minjung Bak (Korea Univ., Korea) | |
| 14:20-14:40 | Discussion |
Won Young Kim (Ulsan Univ., Emergency Medicine, Korea) , Kyoung Eun Lee (Severance Hospital, Nursing, Korea) , Sohyun Lee (Korea Univ. Guro Hospital, Nursing, Korea) , Yujin Jeon (Chungnam National Univ. Hospital Nursing, Korea) , Ji Yeon Choi (Samsung Medical Center, Nursing, Korea) , Byung-hee Hwang (Pusan National Univ. Yangsan Hospital, Nursing, Korea) |
||
Cancer and Heart Failure: Addressing Both Challenges
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 15:20-16:40 | KOR Cancer and Heart Failure: Addressing Both Challenges |
Myeong-Chan Cho (Chungbuk National Univ., Korea)
, Woo-Baek Chung (The Catholic Univ., Korea) |
||
| 암환자에서 심부전의 역학 부터 암환자에서 심부전이 동반되었을때 맞춤형 치료 전략, 약물치료의 근거, 미래의 정밀의료 및 디지털 기술 활용 방안을 공부해보고자 한다. | ||||
| 암과 심부전, 두가지 나쁜 예후가 있는 병을 모두 가진 환자들을 어떻게 더 잘 치료할 수 있을지 심도 깊게 토론해 보고자 한다. | ||||
| 15:20-15:35 | Heart Failure in Cancer Patients: Epidemiology and Pathophysiology |
|
Iksung Cho (Yonsei Univ., Korea) | |
| 15:35-15:50 | Unique Considerations in Cancer-related HF: Chemo Cycles, Frailty, and Treatment Strategies |
|
Eun Kyoung Kim (Sungkyunkwan Univ., Korea) | |
| 15:50-16:05 | Could HF GDMT Similarly Apply in Cancer Patients: Applicability, Recent Evidence, and Gaps |
|
Hyukjin Park (Chonnam National Univ., Korea) | |
| 16:05-16:20 | Future Perspectives: Precision Medicine and Digital Monitoring in Cardio-Oncology |
|
Minjae Yoon (Seoul National Univ., Korea) | |
| 16:20-16:40 | Discussion |
Seo-Yeon Gwak (Korea Univ., Korea) , Jung Sun Cho (The Catholic Univ., Korea) , Hui-Jeong Hwang (Kyung Hee Univ., Korea) |
||
[Physician Educational Session(1)] for Primary Physicians and House Staffs
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 15:00-16:20 | KOR [Physician Educational Session(1)] for Primary Physicians and House Staffs |
Eunseok Jeon (Sungkyunkwan Univ., Korea)
, Han Soo Kim (Bundang 21st Century Clinic, Korea) |
||
| 일차의료기관에서 필요한 심부전 관련 지식을 습득한다. | ||||
| 일차의료 기관에서 마주할 수 있는 심부전 환자에 대한 진단과 분류 접근에 대해 공부해 본다. | ||||
| 15:00-15:20 | Checking and Interpreting Cardiac Biomarkers: When? How Often? |
|
Jung Woo Son (Yonsei Wonju Univ., Korea) | |
| 15:20-15:40 | HF with Preserved EF: Diagnosis and Treatment |
|
Seok-Jae Hwang (Gumdan Top Hospital, Korea) | |
| 15:40-16:00 | HF with Reduced EF: Practical Approach for Optimizing GDMT |
|
Kyeong-Hyeon Chun (Yonsei Univ., Korea) | |
| 16:00-16:20 | Discussion |
Hee-Sun Mun (Yonsei Univ., Korea) , Hee Jeong Lee (Keimyung Univ., Korea) , Sung Il Ha (SOK Hepato-Gastroenterology Clinic Center, Korea) |
||
The Role of AI and Beta-Blockers in Heart Failure Treatment
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room A | ||||
| 14:20-15:30 |
KOR
The Role of AI and Beta-Blockers in Heart Failure Treatment |
Dong-Ju Choi (Seoul National Univ., Korea)
, Sang-Ho Jo (Hallym Univ., Korea) |
||
| 14:20-14:50 | Bisoprolol in HF: Still Essential Against Overdrive |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 14:50-15:20 | Recent Advances and Clinical Applications of AI in Electrocardiography |
|
Junmyung Kwon (Medical AI, Korea) | |
| 15:20-15:30 | Discussion | |||
It's Time to Go to Bed: Sleep Management for HF Patients
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 16:40-18:00 | KOR It's Time to Go to Bed: Sleep Management for HF Patients |
Sang Hyun Ihm (The Catholic Univ., Korea)
, Kyung-Kuk Hwang (Chungbuk National Univ., Korea) |
||
| 심부전 환자에서 나타나는 수면 장애와 수면 질 저하의 원인과 치료에 대해서 마스터 한다. | ||||
| 심부전 환자에서 나타나는 다양한 수면 문제가 나타나지만, 약제 사용과 치료에 제한점이 많아 다학제적 접근이 요구된다. 심부전 환자에서의 수면관리, 수면 관련 심부전 위험 인자의 종류와 관리, 치료에 대한 최신지견을 알아보고자 한다. | ||||
| 16:40-17:00 | Common Night Calls, Sleeping Problems, and Challenges in HF Patients |
|
Junho Hyun (Ulsan Univ., Korea) | |
| 17:00-17:20 | Breathing Matters: Sleep Apnea and Its Impact on Heart Failure |
|
Chang-Ho Yoon (Seoul National Univ., Neurology, Korea) | |
| 17:20-17:40 | Mind Over Matter: Managing Insomnia and Anxiety in HF Patients |
|
Jooyoung Oh (Yonsei Univ., Psychiatry, Korea) | |
| 17:40-18:00 | Discussion |
Bong-Joon Kim (Kosin Univ., Korea) , Se Eun Kim (Yonsei Wonju Univ., Korea) , Sook Jin Lee (Hallym Univ., Korea) , Kyung Eun Ha (Gachon Univ., Korea) |
||
[Joint Session with KPHS] Right Heart Failure and Pulmonary HTN
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | KOR [Joint Session with KPHS] Right Heart Failure and Pulmonary HTN |
Wook-Jin Chung (Gachon Univ., Korea)
, Gi Beom Kim (Seoul National Univ., Pediatrics, Korea) |
||
| 우심부전 및 폐고혈압에 대한 진단과 최신 치료법을 안다. | ||||
| 우심부전과 폐고혈압의 병태생리 및 진단방법, 최신 치료 약제와 치료법에 대한 정보 공유하고 토론하는 세션으로 우심부전과 폐고혈압이 아직도 어렵게 느껴진다면, 이 세션을 들어보자. | ||||
| 15:40-15:55 | Understanding the Right Ventricle: Why It Fails in Pulmonary Hypertension |
|
Wook-Jin Chung (Gachon Univ., Korea) | |
| 15:55-16:10 | Advancing Diagnostics: Imaging and Hemodynamics in Right Heart Failure |
|
Jae-Hyeong Park (Chungnam National Univ., Korea) | |
| 16:10-16:25 | Pulmonary Vasodilators and Beyond: Latest Therapeutic Strategies for Pulmonary Hypertension |
|
Sanghyun Lee (Pusan National Univ., Korea) | |
| 16:25-16:40 | Bridging the Gap: Mechanical Support and Transplantation in End-Stage Right Heart Failure |
|
Ah-Ram Kim (Ulsan Univ., Korea) | |
| 16:40-17:00 | Discussion |
Bong-Joon Kim (Kosin Univ., Korea) , Jae Seung Lee (Ulsan Univ., Pulmonology, Korea) , Ji Hyun Cha (Sungkyunkwan Univ., Korea) , Ran Heo (Hanyang Univ., Korea) |
||
[Physician Educational Session(2)] for Primary Physicians and House Staffs
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room A Learning Objective + Session Rationale + |
||||
| 16:30-17:50 | KOR [Physician Educational Session(2)] for Primary Physicians and House Staffs |
Jae Choon Ryu (Ryu Jae Choon Internal Medicine Clinic, Korea)
, Jin-Oh Choi (Sungkyunkwan Univ., Korea) |
||
| 일차의료기관에서 필요한 심부전 관련 지식을 습득한다. | ||||
| 일차의료 기관에서 마주할 수 있는 심부전 환자에 대한 약제 조절 및 치료법에 대해 공부해 본다. | ||||
| 16:30-16:50 | Mastering Diuretic Therapy in HF: Tips and Challenges |
|
Yoonjee Park (Bucheon Sejong Hospital, Korea) | |
| 16:50-17:10 | Mastering Beta-blocker in HF: Tips and Challenges |
|
Chan Joo Lee (Yonsei Univ., Korea) | |
| 17:10-17:30 | Coordinated HF Management in Primary and Tertiary HF Centers |
|
Sunki Lee (Korea Univ., Korea) | |
| 17:30-17:50 | Discussion |
Sang Wook Park (Yonsei Wonju Univ., Integrated Medicine, Korea) , Min Seok Oh (Bundang Jesaeng Hospital, Korea) , Seong Choon Choe (Green Hospital, Korea) |
||
Inflammatory Heart Disease, Burning Heart
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | ENG Inflammatory Heart Disease, Burning Heart |
Dae-Gyun Park (Hallym Univ., Korea)
, Barry Greenberg (Univ. of California San Diego, USA) |
||
| This session aims to develop a comprehensive understanding of the diagnosis, treatment, and management of inflammatory heart disease—including myocarditis, pericarditis, cardiac sarcoidosis, and drug-induced cardiotoxicity—by highlighting current insights, therapeutic innovations, and real-world clinical practices. | ||||
| Inflammatory heart disease still feels unfamiliar and challenging. Let us undertake a comprehensive review of the most commonly encountered forms of inflammatory heart disease: myocarditis, pericarditis, cardiac sarcoidosis, and drug-induced cardiotoxicity. | ||||
| 09:00-09:15 | Current Insights in Myocarditis: Diagnosis and Treatment Updates |
|
Kye Hun Kim (Chonnam National Univ., Korea) | |
| 09:15-09:30 | Pericarditis, from Etiology to Effective Treatment |
|
Eui-Young Choi (Yonsei Univ., Korea) | |
| 09:30-09:45 | Innovations in the Diagnosis and Treatment of Cardiac Sarcoidosis |
|
Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan) | |
| 09:45-10:00 | Drug-induced Inflammatory Heart Disease in Real Clinical Practice |
|
Jae Yeong Cho (Chonnam National Univ., Korea) | |
| 10:00-10:20 | Discussion |
Jun-Bean Park (Seoul National Univ., Korea) , SungA Bae (Yonsei Univ., Korea) , Taeil Yang (Gachon Univ., Korea) , Ji-Won Hwang (Inje Univ., Korea) |
||
Recently Introduced, But Underused Drugs
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 08:40-10:00 | ENG Recently Introduced, But Underused Drugs |
Myeong-Chan Cho (Chungbuk National Univ., Korea)
, Koichiro Kinugawa (Univ. of Toyama, Japan) |
||
| To understand the mechanisms, clinical evidence, and treatment potential of emerging yet underutilized drugs in heart failure therapy. | ||||
| This session will cover novel agents such as vericiguat, intravenous iron, finerenone, and GLP-1 receptor agonists. Each presentation will focus on their therapeutic mechanisms, clinical trial data, and practical considerations for use in daily practice. The goal is to raise awareness of these promising therapies and encourage appropriate implementation in diverse heart failure populations. | ||||
| 08:40-08:55 | Vericiguat: A Missed Opportunity in Worsening HF with Reduced Ejection Fraction |
|
Ju-Hee Lee (Chungbuk National Univ., Korea) | |
| 08:55-09:10 | Ironing Out Heart Failure: The Role of Ferric Carboxymaltose in HF Management |
|
Hae-Young Lee (Seoul National Univ., Korea) | |
| 09:10-09:25 | Finerenone: The Game Changer of Mineralocorticoid Receptor Antagonist? |
|
Gianluigi Savarese (Karolinska Institutet, Sweden) | |
| 09:25-09:40 | Beyond Diabetes: Can GLP-1 Receptor Agonists Transform HF Care? |
|
Min Gyu Kong (Soon Chun Hyang Univ., Korea) | |
| 09:40-10:00 | Discussion |
Mijoo Kim (Chungnam National Univ., Korea) , Soo Youn Lee (Incheon Sejong Hospital, Korea) , Jeen Hwa Lee (Hallym Univ., Korea) , Yuling Zhang (Sun Yat-sen Memorial Hospital of Sun Yat-sen Univ., China) |
||
Morning Session 2 
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room B | ||||
| 08:00-09:00 |
KOR
Morning Session 2
|
Seok Min Kang (Yonsei Univ., Korea) | ||
| 08:00-08:30 | Jardiance, The First Successful Result for Chronic Heart Failure with Preserved Ejection Fraction | Mi-Na Kim (Korea Univ., Korea) | ||
| 08:30-09:00 | Should Jardiance be Used as 1st Essential Medication for Chronic Heart Failure, Regardless of LVEF | Kyeong-Hyeon Chun (Yonsei Univ., Korea) | ||
[Joint Session with KSSO] The Present and Future Management of Obesity
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 10:30-11:50 | ENG [Joint Session with KSSO] The Present and Future Management of Obesity |
Seok Min Kang (Yonsei Univ., Korea)
, Min-Seon Kim (Ulsan Univ., Endocrinology and Metabolism, Korea) |
||
| This session aims to build a comprehensive understanding of obesity and its broad clinical implications, with a particular focus on its pathophysiologic and therapeutic relevance to heart failure. Through a multidisciplinary approach, the session will explore up-to-date strategies for obesity treatment, including emerging concepts in the management of obese heart failure. | ||||
| Obesity is a disease—and in patients with heart failure, it becomes an even more serious condition. This joint session with KSSO is structured to provide an integrated view of obesity from both endocrinology and cardiology perspectives. The alternating structure of endocrinology and cardiology topics is designed to encourage multidisciplinary insights and foster clinical collaboration. | ||||
| 10:30-10:45 | Why Do We Treat Obesity? - The Current and Future Threat of Obesity |
|
Yang Im Hur (CHA Univ., Family Medicine, Korea) | |
| 10:45-11:00 | Obesity and Heart Failure - Pathophysiologic Links and Effects of Anti-obesity Treatment |
|
Gianluigi Savarese (Karolinska Institutet, Sweden) | |
| 11:00-11:15 | Current and Emerging Medications for Obesity Management - Step by Step Guidance |
|
Jang Won Son (The Catholic Univ., Endocrinology and Metabolism, Korea) | |
| 11:15-11:30 | NuSH and Other Treatment Options in the Management of Obese Heart Failure |
|
Chan Joo Lee (Yonsei Univ., Korea) | |
| 11:30-11:50 | Discussion |
Seo Young Kang (Eulji Univ. ,Family Medicine, Korea) , Minjoo Kim (Hannam Univ., Food and Nutrition, Korea) , Sang Min Park (Eulji Univ., Korea) , Jung Woo Son (Yonsei Wonju Univ., Korea) |
||
Hypertrophic Cardiomyopathy in 2025
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | ENG Hypertrophic Cardiomyopathy in 2025 |
Dong Heon Yang (Kyungpook National Univ., Korea)
, Eui-Young Choi (Yonsei Univ., Korea) |
||
| This session aims to provide an up-to-date understanding of the evolving landscape of hypertrophic cardiomyopathy (HCM) management by addressing advances in genetics and precision medicine, the role of cardiac imaging in the era of myosin inhibitors, and the development of novel pharmacologic therapies. | ||||
| As knowledge and technology in HCM rapidly advance, 2025 represents a turning point in the way this disease is diagnosed, risk-stratified, and treated. | ||||
| 09:00-09:20 | Genetics and Precision Medicine in Diagnosing and Risk Stratification in HCM |
|
Seitaro Nomura (The Univ. of Tokyo, Japan) | |
| 09:20-09:40 | Role of Imaging in HCM in the Era of Cardiac Myosin Inhibitor |
|
Chi Young Shim (Yonsei Univ., Korea) | |
| 09:40-10:00 | From Beta-blockers to Myosin Inhibitors: Evolving Pharmacologic Therapies for HCM |
|
Carolyn Ho (Brigham and Women's Hospital, USA) | |
| 10:00-10:20 | Discussion |
Jang-Won Son (Yeungnam Univ., Korea) , Hyun-Jung Lee (Yonsei Univ., Korea) , Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) , Jung Hyun Choi (Pusan National Univ., Korea) |
||
[Joint Session with CHFA] Artificial Intelligence in HF
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 10:20-11:40 | ENG [Joint Session with CHFA] Artificial Intelligence in HF |
Dong-Ju Choi (Seoul National Univ., Korea)
, Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China) |
||
| To explore how artificial intelligence is being applied in the diagnosis, prognosis, and treatment optimization of heart failure. | ||||
| This session will introduce AI-driven tools for heart failure diagnosis, mortality prediction, and outcome improvement. It will feature real-world applications of multimodal deep learning and present emerging digital health tools from China. The discussion aims to enhance clinicians' familiarity with the integration of AI in heart failure practice and foster international collaboration. | ||||
| 10:20-10:35 | Artificial Intelligence for the Diagnosis of Heart Failure |
|
Jihun Jang (Inha Univ., Korea) | |
| 10:35-10:50 | Multimodal Deep Learning for Predicting Mortality in Heart Failure |
|
Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China) | |
| 10:50-11:05 | Use of AI in Improving Outcomes in Heart Failure |
|
Jong-Chan Youn (The Catholic Univ., Korea) | |
| 11:05-11:20 | New AI-enabled Heart Failure Management Tools in China |
|
Yuling Zhang (Sun Yat-sen Memorial Hospital of Sun Yat-sen Univ., China) | |
| 11:20-11:40 | Discussion |
Joonghee Kim (Seoul National Univ., Emergency Medicine, Korea) , Sung-Ji Park (Sungkyunkwan Univ., Korea) , Hyo Suk Ahn (The Catholic Univ., Korea) , Sunki Lee (Korea Univ., Korea) |
||
Opening Ceremony
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
| Room B | ||||
| 12:10-12:40 | ENG Opening Ceremony | |||
[Joint Session with HFA-ESC] How to Enhance a Personalized Strategy for HF Management
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | ENG [Joint Session with HFA-ESC] How to Enhance a Personalized Strategy for HF Management |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Gianluigi Savarese (Karolinska Institutet, Sweden) |
||
| This session aims to explore practical and evidence-based strategies for implementing personalized heart failure (HF) care, focusing on decongestion, biomarker-guided therapy, and optimization during the transitional period following acute decompensation. | ||||
| As heart failure management evolves toward individualized care, a personalized approach is essential to improve patient outcomes across diverse clinical scenarios. This joint session with the European Society of Cardiology – Heart Failure Association (HFA-ESC) highlights critical components of tailored HF management. | ||||
| 10:40-11:00 | Dietary Sodium, Fluid Intake and Decongestion in Heart Failure |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 11:00-11:20 | Biomarkers: Optimizing Treatment Guidance in Heart Failure |
|
Byung Su Yoo (Yonsei Wonju Univ., Korea) | |
| 11:20-11:40 | Optimization of HF Care during Transitional Period in Acute HF Patients |
|
Marco Metra (University of Brescia, Italy) | |
| 11:40-12:00 | Discussion |
Sung-Hee Shin (Inha Univ., Korea) , Chi Young Shim (Yonsei Univ., Korea) , In-Chang Hwang (Seoul National Univ., Korea) , Novi Yanti Sari (Siloam Hospitals Lippo Village, Jakarta, Indonesia) |
||
Luncheon Session 8 
ATTR-CM and Tafamidis (Vyndamax (Tafamidis))
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Room B | ||||
| 12:20-13:20 |
ENG
Luncheon Session 8 ATTR-CM and Tafamidis (Vyndamax (Tafamidis)) |
Eunseok Jeon (Sungkyunkwan Univ., Korea) | ||
| 12:20-12:50 | The Multidisciplinary Management of ATTR Amyloidosis with Tafamidis | Marcus Urey (Univ. of California San Diego, USA) | ||
| 12:50-13:20 | Treatment of ATTR-CM with Tafamidis in Korea | Ran Heo (Hanyang Univ., Korea) | ||
Hurdle Race of LVAD - Complications and Treatments
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 13:20-14:40 | ENG Hurdle Race of LVAD - Complications and Treatments |
Jae-Joong Kim (Ulsan Univ., Korea)
, Sukkeun Hong (Bucheon Sejong Hospital, Korea) |
||
| To recognize the common complications associated with LVAD therapy and understand key strategies for their prevention and management. | ||||
| This session will address bleeding, thrombosis, valvular regurgitation, arrhythmias, and optimization challenges in LVAD-supported patients. Experts will provide insight into their pathophysiology, clinical impact, and mitigation strategies. The session aims to improve outcomes by guiding multidisciplinary care in this complex patient population. | ||||
| 13:20-13:35 | Delicate Balance between Thrombosis and Bleeding: Prevention and Management of Bleeding in LVAD Patients |
|
Jeehoon Kang (Seoul National Univ., Korea) | |
| 13:35-13:50 | Can a Little Leak Sink a Ship? Valvular Regurgitation before and after LVAD Implantation |
|
Kyung-Hee Kim (Incheon Sejong Hospital, Korea) | |
| 13:50-14:05 | Listen to the Heart Beat: the Struggle against Arrhythmia during LVAD Support |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 14:05-14:20 | Optimizing LVAD Outcome - Learn from Japanese Experience |
|
Koichiro Kinugawa (Univ. of Toyama, Japan) | |
| 14:20-14:40 | Discussion |
Yoonjee Park (Bucheon Sejong Hospital, Korea) , So young Lee (The Catholic Univ., Korea) , Hee Jeong Lee (Keimyung Univ., Korea) , Yang Hyun Cho (Sungkyunkwan Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
Luncheon Session 2
Advancing Quality in Heart Failure: Entresto at the Core
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
| Room B | ||||
| 12:40-13:40 |
ENG
Luncheon Session 2 Advancing Quality in Heart Failure: Entresto at the Core |
Byung Su Yoo (Yonsei Wonju Univ., Korea) | ||
| 12:40-13:40 | Overcoming Clinical Inertia: Optimizing Sacubitril/Valsartan and GDMT for Heart Failure with a Need for Speed | Stephen Greene (Duke Univ., USA) | ||
Luncheon Session 5
Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room B | ||||
| 12:00-13:00 |
ENG
Luncheon Session 5 Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT |
Kyu Hyung Ryu (Techo Santepheap National Hospital, Cambodia)
, Seongwoo Han (Hallym Univ., Korea) |
||
| 12:00-12:45 | Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT | Barry Greenberg (Univ. of California San Diego, USA) | ||
| 12:45-13:00 | Discussion | |||
[Joint Session with HFSA] A Fresh Look on Cardiovascular Kidney Metabolic Syndrome
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 13:40-15:00 | ENG [Joint Session with HFSA] A Fresh Look on Cardiovascular Kidney Metabolic Syndrome |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Barry Greenberg (Univ. of California San Diego, USA) |
||
| This session aims to provide a comprehensive understanding of the Cardiovascular Kidney Metabolic (CKM) Syndrome. | ||||
| This joint session with the Heart Failure Society of America (HFSA) revisits the evolving concept of Cardiovascular Kidney Metabolic (CKM) syndrome, which highlights the complex and bidirectional interplay between cardiovascular, renal, and metabolic dysfunction in heart failure. | ||||
| 13:40-14:00 | Pathophysiology and Risk Staging of CKM Syndrome |
|
Stephen Greene (Duke Univ., USA) | |
| 14:00-14:20 | Trends in the Prevalence of CKM Syndrome in Korean HF Patients |
|
Jin Joo Park (Seoul National Univ., Korea) | |
| 14:20-14:40 | Treatment for Advanced CKM Syndrome: Present and Future |
|
Stephen Greene (Duke Univ., USA) | |
| 14:40-15:00 | Discussion |
Min-Seok Kim (Ulsan Univ., Korea) , Sung-Hee Shin (Inha Univ., Korea) , Chan Joo Lee (Yonsei Univ., Korea) |
||
Hematologic Problems Related to Heart Failure
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | ENG Hematologic Problems Related to Heart Failure |
Eunseok Jeon (Sungkyunkwan Univ., Korea)
, Chang-Ki Min (The Catholic Univ., Korea) |
||
| To understand the pathophysiology and clinical implications of anemia, CHIP, cardiac amyloidosis, and hematologic malignancies in heart failure, and how these conditions impact diagnostic and therapeutic strategies. | ||||
| This session will explore key hematologic conditions frequently encountered in heart failure, including anemia, clonal hematopoiesis, and amyloidosis. It will also highlight the cardiovascular complications of hematologic malignancies and treatment-related cardiotoxicity. Through case-based and mechanistic insights, the session aims to provide a multidisciplinary perspective on integrating hematologic factors into heart failure management. | ||||
| 13:00-13:15 | Iron Deficiency, Anemia, and Transfusion in Heart Failure |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 13:15-13:30 | CHIP (Clonal Hematopoiesis of Indeterminate Potential) in CVD: A New Frontier in Cardio-Hematology |
|
Jun-Bean Park (Seoul National Univ., Korea) | |
| 13:30-13:45 | AL Amyloidosis: What Cardiologists Need to Know |
|
Jeong-Eun Yi (The Catholic Univ., Korea) | |
| 13:45-14:00 | Atrial Fibrillation in Cardiac Amyloidosis |
|
Yasuhiro Izumiya (Kumamoto Univ., Japan) | |
| 14:00-14:20 | Discussion |
Kyu-Yong Ko (Inje Univ., Korea) , Hyung Yoon Kim (Incheon Sejong Hospital, Korea) , Kyeong-Hyeon Chun (Yonsei Univ., Korea) |
||
[Joint Session with KOVAS] Sports and Vessels in HF
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 15:00-16:20 | ENG [Joint Session with KOVAS] Sports and Vessels in HF |
Ki-Chul Sung (Sungkyunkwan Univ., Korea)
, Eung Ju Kim (Korea Univ., Korea) |
||
| To understand the physiological and clinical impact of exercise and rehabilitation in heart failure, with a focus on vascular function, pulmonary hypertension, and exercise prescription. | ||||
| This session will examine how physical activity affects vascular health and pulmonary pressures in heart failure patients. It will also provide practical guidance on safe exercise prescription and highlight the latest evidence supporting cardiac rehabilitation. The goal is to promote safe and effective integration of exercise into HF care. | ||||
| 15:00-15:15 | Impact of Physical Activity on Vascular Function in HF: Mechanisms and Clinical Implications |
|
Jong-Young Lee (Sungkyunkwan Univ., Korea) | |
| 15:15-15:30 | Benefits, Risks, and Practical Guidance of Exercise Prescription in HF Patients |
|
Byeong Ju Lee (Pusan National Univ., Rehabilitation Medicine, Korea) | |
| 15:30-15:45 | Exercise-induced Pulmonary Hypertension in HF: Detection, Assessment, and Management |
|
Jeong Hoon Yang (Sungkyunkwan Univ., Korea) | |
| 15:45-16:00 | Latest Evidence and Future Directions of Cardiac Rehabilitation in HF |
|
Jidong Sung (Sungkyunkwan Univ., Korea) | |
| 16:00-16:20 | Discussion |
Hyemoon Chung (Kyung Hee Univ., Korea) , Sung Woo Cho (Inje Univ., Korea) , Hyung Joon Joo (Korea Univ., Korea) , Hyo-In Choi (Sungkyunkwan Univ., Korea) |
||
[Joint Session with JHFS] ATTR Amyloidosis
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 15:20-16:40 | ENG [Joint Session with JHFS] ATTR Amyloidosis |
Jin-Oh Choi (Sungkyunkwan Univ., Korea)
, Koichiro Kinugawa (Univ. of Toyama, Japan) |
||
| This session aims to deepen understanding of transthyretin amyloid cardiomyopathy (ATTR-CM) in Asian populations by addressing challenges in diagnosis, regional clinical characteristics, novel imaging techniques, and real-world treatment outcomes. | ||||
| This joint session with the Japanese Heart Failure Society (JHFS) highlights the importance of recognizing and managing transthyretin amyloid cardiomyopathy (ATTR-CM) in Asian populations, where clinical awareness and diagnostic access are still evolving. | ||||
| 15:20-15:35 | Patient Journey to Diagnosis of ATTR Cardiomyopathy in Asian Population |
|
Jin Endo (Keio Univ., Japan) | |
| 15:35-15:50 | Diagnostic Pitfall and Clinical Characteristics of ATTR Cardiomyopathy in Asian Population |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:50-16:05 | Novel Imaging for Diagnosis and Follow-up of ATTR Cardiomyopathy |
|
Yasuhiro Izumiya (Kumamoto Univ., Japan) | |
| 16:05-16:20 | Real-world Treatment and Prognosis of ATTR Cardiomyopathy |
|
Jaewon Oh (Yonsei Univ., Korea) | |
| 16:20-16:40 | Discussion |
Kyu-Yong Ko (Inje Univ., Korea) , Ji-Hyun Kim (The Catholic Univ., Korea) , Jong-Chan Youn (The Catholic Univ., Korea) , Hyemoon Chung (Kyung Hee Univ., Korea) |
||
Hot Topics in HF (Latest Research Review)
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 16:30-17:50 | ENG Hot Topics in HF (Latest Research Review) |
Hyun-Jai Cho (Seoul National Univ., Korea)
, Barry Greenberg (Univ. of California San Diego, USA) |
||
| To review and understand key recent advances in basic and clinical heart failure research from different global regions. | ||||
| This session will highlight top research papers in basic science and clinical studies from Europe, the USA, and Asia, published during 2024-2025. Each speaker will present major findings and their implications for practice. The session aims to provide a global overview of cutting-edge HF research and stimulate future collaboration. | ||||
| 16:30-16:50 | Top 3 Basic Research in Heart Failure (2024-2025) |
|
Jaewon Oh (Yonsei Univ., Korea) | |
| 16:50-17:10 | Top 3 Clinical Research in Europe (2024-2025) |
|
Jin Joo Park (Seoul National Univ., Korea) | |
| 17:10-17:30 | Top 3 Clinical Research in Asia (2024-2025) |
|
Jong-Chan Youn (The Catholic Univ., Korea) | |
| 17:30-17:50 | Discussion |
Min Sun Kim (Pusan National Univ., Korea) , Minjung Bak (Korea Univ., Korea) , Moon-Seung Soh (Ajou Univ., Korea) , Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China) |
||
When to Look for Amyloidosis? Early Clinical Clues to Raise Diagnostic Suspicion
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room B | ||||
| 14:20-15:30 |
ENG
When to Look for Amyloidosis? Early Clinical Clues to Raise Diagnostic Suspicion |
Jin-Oh Choi (Sungkyunkwan Univ., Korea)
, Marcus Urey (Univ. of California San Diego, USA) |
||
| 14:20-14:50 | Navigating Early Diagnosis of ATTR Amyloidosis in Clinical Practice |
|
Marcus Urey (Univ. of California San Diego, USA) | |
| 14:50-15:05 | Sharing Real World Experiences of Diagnosed Amyloidosis I |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 15:05-15:20 | Sharing Real World Experiences of Diagnosed Amyloidosis II |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:20-15:30 | Discussion | Yoonjee Park (Bucheon Sejong Hospital, Korea) | ||
Focus on Heart Failure in Women
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 16:40-18:00 | ENG Focus on Heart Failure in Women |
Myung-A Kim (Seoul National Univ., Korea)
, Mi-Seung Shin (Gachon Univ., Korea) |
||
| This session aims to enhance awareness and understanding of the unique burden, risk factors, and pathophysiological characteristics of heart failure in women, and to explore sex-specific approaches to cardiovascular risk assessment, management, and genetic cardiomyopathies. | ||||
| Despite increasing recognition, heart failure in women remains underdiagnosed and undertreated, with sex-specific factors contributing to disparities in care and outcomes. This session highlights recent advances and expert perspectives on addressing these gaps. | ||||
| 16:40-17:00 | The Disproportionate Burden of Heart Failure in Women: Advances and Expert Perspectives |
|
Barry Greenberg (Univ. of California San Diego, USA) | |
| 17:00-17:20 | Women Specific Cardiovascular Risk and Management |
|
Seong-Mi Park (Korea Univ., Korea) | |
| 17:20-17:40 | Sex Differences in Genetic Cardiomyopathy |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 17:40-18:00 | Discussion |
Jung Woo Son (Yonsei Wonju Univ., Korea) , Mi-Hyang Jung (The Catholic Univ., Korea) , In-Jeong Cho (Ewha Womans Univ., Korea) |
||
Lucky Draw & Closing Remark
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Room B | ||||
| 17:50-18:10 | ENG Lucky Draw & Closing Remark | |||
[Educational Session for HF Newbies 1] Outpatient Management
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | KOR [Educational Session for HF Newbies 1] Outpatient Management |
Sung Kee Ryu (Ewha Womans Univ., Korea)
, Seonghoon Choi (Hallym Univ., Korea) |
||
| 심부전 진료 초심자들이 외래 환경에서의 약물 치료, 관상동맥질환, 심방세동, 만성콩팥병 동반 시 관리 전략을 종합적으로 이해하고 임상에 적용할 수 있도록 한다. | ||||
| 외래 진료에서 심부전 환자 관리의 기본 원칙과 주요 동반질환의 실제적 접근을 체계적으로 익힐 수 있도록 구성하였다. | ||||
| 09:00-09:15 | GDMT Implementation for Outpatients: Dose up Titration, Novel Drugs and Monitoring |
|
Dae-Hwan Bae (Bucheon Sejong Hospital, Korea) | |
| 09:15-09:30 | Ischemic Heart Disease in HF Patients: How Should We Manage CAD? |
|
Gyu Chul Oh (The Catholic Univ., Korea) | |
| 09:30-09:45 | What Is the Best Strategy of AF Management in HF Patients |
|
Tae-Hoon Kim (Yonsei Univ., Korea) | |
| 09:45-10:00 | How Do We Prescribe HF Medications in CKD Patients |
|
Hyemoon Chung (Kyung Hee Univ., Korea) | |
| 10:00-10:20 | Discussion |
Kyu-Yong Ko (Inje Univ., Korea) , Ji Hyun Cha (Sungkyunkwan Univ., Korea) , Kyung Eun Ha (Gachon Univ., Korea) |
||
[Joint Session with KHRS] Arrhythmia and Device Therapy in HF
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room B Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | ENG [Joint Session with KHRS] Arrhythmia and Device Therapy in HF |
Dae-Gyun Park (Hallym Univ., Korea)
, Seil Oh (Seoul National Univ., Korea) |
||
| To understand the indications, benefits, and risks of catheter ablation and cardiac resynchronization therapy in heart failure patients with arrhythmia. | ||||
| This session will review catheter ablation strategies in heart failure with atrial fibrillation, including patient selection and real-world outcomes. It will also discuss the detection and management of asymptomatic arrhythmias, and present practical guidance on optimizing CRT. By integrating electrophysiologic interventions into heart failure care, the session aims to improve rhythm control and patient prognosis. | ||||
| 15:40-15:55 | HF with Atrial Fibrillation: Patients for Whom Catheter Ablation May be Beneficial |
|
Jun Kim (Ulsan Univ., Korea) | |
| 15:55-16:10 | HF with Atrial Fibrillation: Common and Rare Concerns of Catheter Ablation |
|
Jiwon Seo (Yonsei Univ., Korea) | |
| 16:10-16:25 | How to Diagnose and Manage Asymptomatic Arrhythmia in HF Patients? |
|
Eue-Keun Choi (Seoul National Univ., Korea) | |
| 16:25-16:40 | A Practical Approach to Optimize Cardiac Resynchronization Therapy |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 16:40-17:00 | Discussion |
Tae-Hoon Kim (Yonsei Univ., Korea) , Yoonjee Park (Bucheon Sejong Hospital, Korea) , Youngjin Cho (Seoul National Univ., Korea) |
||
Up-to Date Basic/Translational Research in Heart Failure
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 08:40-10:00 | ENG Up-to Date Basic/Translational Research in Heart Failure |
Wook-Jin Chung (Gachon Univ., Korea)
, Hun-Jun Park (The Catholic Univ., Korea) |
||
| To familiarize participants with the latest discoveries in epigenetic regulation, nuclear architecture, inflammatory signaling, and spatial transcriptomics, and to explore how these mechanisms inform the development of next-generation heart failure therapies. | ||||
| This session aims to highlight emerging directions in basic and translational research that deepen our understanding of heart failure pathophysiology and identify novel therapeutic targets. | ||||
| 08:40-08:55 | Epigenetics in Heart Failure |
|
Chul-Hwan Lee (Seoul National Univ., Epigenetics and Molecular Pharmacology, Korea) | |
| 08:55-09:10 | Inflammatory Cytokines as a New Therapeutic Target in Heart Failure |
|
Seitaro Nomura (The Univ. of Tokyo, Japan) | |
| 09:10-09:25 | Spatial RNA Sequencing in Heart Failure |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 09:25-09:40 | Advances in Treatment of Genetic Cardiomyopathies |
|
Carolyn Ho (Brigham and Women's Hospital, USA) | |
| 09:40-10:00 | Discussion |
Jun-Bean Park (Seoul National Univ., Korea) , Jaewon Oh (Yonsei Univ., Korea) , Soo Yong Lee (Pusan National Univ., Korea) |
||
[Educational Session for HF Newbies 2] In-patient Management
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 10:30-11:50 | KOR [Educational Session for HF Newbies 2] In-patient Management |
Min-Seok Kim (Ulsan Univ., Korea)
, Jeong Hoon Yang (Sungkyunkwan Univ., Korea) |
||
| 입원한 심부전 환자에서 혈역학적 상태에 따른 치료, 급성 합병증 대응, 고위험 환자의 advanced therapy 고려, 퇴원 전 약물 치료 최적화 전략을 실제 임상에 적용할 수 있도록 한다. | ||||
| 심부전 입원 환자의 평가 및 치료 전략을 단계별로 이해하고, 중증도 평가부터 퇴원 전까지의 핵심 흐름을 임상 사례 기반으로 정리하고자 구성하였다. | ||||
| 10:30-10:45 | Wet, Dry, Warm, Cold: Hemodynamic-guided Therapy in Hospitalized HF Patients |
|
Mi-Hyang Jung (The Catholic Univ., Korea) | |
| 10:45-11:00 | Advanced Heart Failure: When to Consider Mechanical Circulatory Support or Transplant |
|
Ah-Ram Kim (Ulsan Univ., Korea) | |
| 11:00-11:15 | Tough Calls in Acute HF: Arrhythmia and Renal Dysfunction |
|
Hyung Yoon Kim (Incheon Sejong Hospital, Korea) | |
| 11:15-11:30 | How to Optimize HF Management before Discharge: Setting up HF Patients for Long-term Success |
|
Dong-Hyuk Cho (Korea Univ., Korea) | |
| 11:30-11:50 | Discussion |
Chang-Yeon Kim (Daegu Catholic Univ., Korea) , Jihee Son (Sungkyunkwan Univ., Korea) , Yuran Ahn (The Catholic Univ., Korea) |
||
KSHF Lifetime Achievement Award
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room B | ||||
| 17:10-18:10 | KOR KSHF Lifetime Achievement Award |
Dae-Gyun Park (Hallym Univ., Korea)
, Byung Su Yoo (Yonsei Wonju Univ., Korea) |
||
| 17:10-17:15 | Introduction of Lifetime Achievement Award | Wook-Jin Chung (Gachon Univ., Korea) | ||
| 17:15-17:35 | History of Heart Failure Treatment |
|
Myung-A Kim (Seoul National Univ., Korea) | |
| 17:35-17:40 | Introduction of Lifetime Achievement Award | Wook-Jin Chung (Gachon Univ., Korea) | ||
| 17:40-18:00 | The Heart Failure Odyssey: From Bench to Cyber |
|
Dong-Ju Choi (Seoul National Univ., Korea) | |
| 18:00-18:10 | Congratulatory Remarks | Byung Su Yoo (Yonsei Wonju Univ., Korea) | ||
Treatment of HF Related to Adult Congenital Heart Diseases
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 10:20-11:40 | KOR Treatment of HF Related to Adult Congenital Heart Diseases |
Sukkeun Hong (Bucheon Sejong Hospital, Korea)
, June Huh (Sungkyunkwan Univ., Pediatrics, Korea) |
||
| 성인 선천성 심질환에서 심부전의 발생 기전과 평가 방법, 약물치료, 부정맥 동반 시 관리, 수술적 중재의 시기 및 치료 전략을 종합적으로 이해한다. | ||||
| 심부전 진료 영역에 있어서 성인 선천성 심질환 환자가 점차 많아짐에 따라, 복합적인 해부학적 특성과 동반 질환을 고려한 맞춤형 치료 전략을 이해하기 위해 구성되었다. | ||||
| 10:20-10:35 | Mechanism and Work-up for HF in ACHD |
|
Lucy Youngmin Eun (Yonsei Univ., Pediatrics, Korea) | |
| 10:35-10:50 | Current Overview in HF Medication in ACHD |
|
Hyun Chung (Bucheon Sejong Hospital, Pediatrics, Korea) | |
| 10:50-11:05 | Management of HF with Arrythmia in ACHD |
|
Mikyoung Song (Seoul National Univ., Pediatrics, Korea) | |
| 11:05-11:20 | Surgical Treatment of Advanced HF in ACHD |
|
Yu Rim Shin (Yonsei Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 11:20-11:40 | Discussion |
Jung Yoon Kim (Bucheon Sejong Hospital, Pediatrics, Korea) , Kyung-Jin Ahn (Gachon Univ., Pediatrics, Korea) , Se Yong Jung (Yonsei Univ., Pediatrics, Korea) , Sungkyu Cho (Seoul National Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
Luncheon Session 3 
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
| Room C | ||||
| 12:40-13:40 |
KOR
Luncheon Session 3
|
Kee-Sik Kim (Daegu Catholic Univ., Korea)
, Sung Kee Ryu (Ewha Womans Univ., Korea) |
||
| 12:40-13:10 | Effects of Carvedilol on Heart Failure with Mildly Reduced or Preserved Ejection Fraction | Jaewon Oh (Yonsei Univ., Korea) | ||
| 13:10-13:40 | Heart Failure and Improved Ejection Fraction : Potential Role of Beta-Blockers & Proven Efficacy of Dilatrend SR in Heart Failure Patients | Junho Hyun (Ulsan Univ., Korea) | ||
Luncheon Session 9 
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Room C | ||||
| 12:20-13:10 |
KOR
Luncheon Session 9
|
Jin-Ok Jeong (Chungnam National Univ., Korea) | ||
| 12:20-13:10 | Shingles in Patients with Heart Failure: Why Prevention Matters | Seong-Mi Park (Korea Univ., Korea) | ||
Promotion and Strategies for Raising Awareness of Heart Failure and Addressing Disease Burden
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 13:40-15:00 | KOR Promotion and Strategies for Raising Awareness of Heart Failure and Addressing Disease Burden |
Seong-Mi Park (Korea Univ., Korea)
, Jong-Young Lee (Sungkyunkwan Univ., Korea) |
||
| 심부전에 대한 대중 인식의 현주소를 이해하고, 교육 캠페인, 정책 메시지, 미디어 활용 등 다양한 채널을 통한 인식 개선 전략을 고찰하는 기회를 만든다. | ||||
| 심부전 홍보위원회와 함께하는 심부전 인식개선 방안 프로젝트. 심부전의 사회적 인식을 재고하고, 환자·의료인·일반 대중을 아우르는 효과적인 커뮤니케이션 및 정책 전략을 세우기 위한 다각적 접근을 제시하고자 한다. | ||||
| 13:40-13:55 | The Launch of Heart Failure Awareness Week - Why Should We Pay Attention? |
|
Kang-Un Choi (Yeungnam Univ., Korea) | |
| 13:55-14:10 | Effective Strategies for Heart Failure Awareness |
|
Minjae Yoon (Seoul National Univ., Korea) | |
| 14:10-14:25 | Reclassifying Heart Failure as a Severe Disease - Why is It Necessary? |
|
Junho Hyun (Ulsan Univ., Korea) | |
| 14:25-14:40 | Awareness of Heart Failure from the Media |
|
Sun Mi Kwon (The JoongAng, Korea) | |
| 14:40-15:00 | Discussion |
Kyung-Hee Kim (Incheon Sejong Hospital, Korea) , Sukmin Seo (The Catholic Univ., Korea) , Jiwon Seo (Yonsei Univ., Korea) , Ji-young You (Korean Doctors Weekly, Korea) , JinHan Lee (THE DONG-A ILBO, Korea) |
||
Oral Presentation & HF Research Award
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room C | ||||
| 09:00-10:20 | ENG Oral Presentation & HF Research Award |
Jin-Ok Jeong (Chungnam National Univ., Korea)
, Kye Hun Kim (Chonnam National Univ., Korea) |
||
| Judges: Min Gyu Kong (Soon Chun Hyang Univ., Korea), Bong-Joon Kim (Kosin Univ., Korea), Jong-Ho Nam (Yeungnam Univ., Korea), Ju-Hee Lee (Chungbuk National Univ., Korea) | ||||
| 09:00-09:10 | Deep Learning-based Modeling of Gender-Affirming Hormone Therapy and Circulating miRNA Signatures to Predict Heart Failure Risk in Transgender Individuals | Rifaldy Fajar (IMCDS-BRF, Indonesia) | ||
| 09:10-09:20 | Clinical Implications of Significant Tricuspid Regurgitation in LVAD Recipients: Prognostic Relevance and Postoperative Trajectory | Heayoung Shin (Sungkyunkwan Univ., Korea) | ||
| 09:20-09:30 | Immunopathologic Features of Biopsy-Confirmed Myocarditis after COVID-19 mRNA Vaccination | Eui-Soon Kim (The Catholic Univ., Korea) | ||
| 09:30-09:40 | Comparative Prognostic Value of Frailty Assessment Tools in Older Patients with Heart Failure: A Post-hoc Analysis of FRAGILE-HF | Yoshiaki Ikeda (Juntendo Univ., Japan) | ||
| 09:40-09:50 | High Versus Low Positive End-Expiratory Pressure in Mechanically Ventilated Patients with Acute Heart Failure | Min-Seok Kim (Ulsan Univ., Korea) | ||
| 09:50-10:00 | Relationship between Left Ventricular Reverse Remodeling and Guideline-Directed Medical Therapy Intensity Score in De Novo Heart Failure with Reduced Ejection Fraction Patients: Insight from TRANS-HF trial | Taeil Yang (Gachon Univ., Korea) | ||
| 10:00-10:10 | Real-world Eligibility of Finerenone in Patients with Heart Failure: Insights from the Korean Heart Failure III (KorHF III) Registry | Moojun Kim (Yonsei Univ., Korea) | ||
| 10:10-10:20 | Impact of Cardiac Contractility Modulation on Reverse Remodeling and Clinical Outcomes in Heart Failure: A Systematic Review and Meta-analysis | David Yobel (Ngoerah Hospital, Indonesia) | ||
Street HF Fighters
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Agora | ||||
| 08:40-10:00 | ENG Street HF Fighters |
Jae-Hyeong Park (Chungnam National Univ., Korea)
, Sung-Hee Shin (Inha Univ., Korea) |
||
| Judges: Jihoon Kim (Hallym Univ., Thoracic and Cardiovascular Surgery, Korea), Sook Jin Lee (Hallym Univ., Korea), Kyeong-Hyeon Chun (Yonsei Univ., Korea), Jae Yeong Cho (Chonnam National Univ., Korea) | ||||
| 08:40-08:53 | Late-onset Cerebral Toxoplasmosis Mimicking Brain Metastasis in a Heart Transplant Recipient | Jewook Shin (Seoul National Univ., Korea) | ||
| 08:53-09:06 | Case Report: A Case of Pulmonary Hypertension Developing in Laubry-Pezzi Syndrome and Progressing to Eisenmenger Syndrome | Seng Socheat (Techo Santepheap National Hospital, Cambodia) | ||
| 09:06-09:19 | Role of Electron Microscopic Evaluation in Transplant Decisions of Advanced Chemotherapyinduced Cardiomyopathy | Taegu Won (The Catholic Univ., Korea) | ||
| 09:19-09:32 | An Unusual Presentation of Acute Idiopathic Right Ventricular Failure | Natalie Min Yi Aw (National Heart Centre Singapore, Singapore) | ||
| 09:32-09:45 | Fulminant Myocarditis with Multiorgan Failure Managed with ECMO and IV Steroid | Yuran Ahn (The Catholic Univ., Korea) | ||
| 09:45-09:58 | Acute Heart Failure Caused by Acute Hypoxemia in a Polysensitized Patient | Anuar Zhunussov (National Scientific Medical Center, Kazakhstan) | ||
Respiratory Management for HF Patients: Approach on SOB, COPD, Mechanical Ventilator
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 15:20-16:40 | KOR Respiratory Management for HF Patients: Approach on SOB, COPD, Mechanical Ventilator |
Choong-Won Goh (Ewha Womans Univ., Korea)
, Seongwoo Han (Hallym Univ., Korea) |
||
| 호흡기내과적 관점 및 심장내과적 관점에서의 cor pulmonale 환자의 진단과 치료를 이해하고 심부전 환자에서의 호흡기계 치료 전략을 습득한다. | ||||
| 호흡곤란을 호소하는 환자 중 심장내과 질환과 호흡기 내과 질환을 동시에 가지는 경우가 많고 이러한 환자의 치료는 매우 어렵다. 따라서 두가지 원인의 호흡곤란을 가지고 있는 환자를 어떻게 더 잘 진단하고 치료할지에 대한 전략을 모색해 본다. | ||||
| 15:20-15:35 | Cor Pulmonale: Is This the Pulmonic Disease? |
|
Jae Seung Lee (Ulsan Univ., Pulmonology, Korea) | |
| 15:35-15:50 | Cor Pulmonale: Is This the Cardiac Disease? |
|
Hyo-In Choi (Sungkyunkwan Univ., Korea) | |
| 15:50-16:05 | Heart Failure and COPD: A Deadly Combination? |
|
Sua Kim (Korea Univ., Critical Care Medicine, Korea) | |
| 16:05-16:20 | Oxygen Therapy, NIV, HFNC, and Mechanical Ventilation in HF |
|
Won-Young Kim (Chung-Ang Univ., Pulmonology, Korea) | |
| 16:20-16:40 | Discussion |
Hang-Jea Jang (Inje Univ., Pulmonology, Korea) , Hyeonju Jeong (Myongji Hospital, Korea) , Junho Hyun (Ulsan Univ., Korea) |
||
Young Investigator Award Session
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room C | ||||
| 10:40-12:01 | ENG Young Investigator Award Session |
Mi-Seung Shin (Gachon Univ., Korea)
, Seonghoon Choi (Hallym Univ., Korea) |
||
| Judges: Jang-Won Son (Yeungnam Univ., Korea), Minjae Yoon (Seoul National Univ., Korea), Mi-Hyang Jung (The Catholic Univ., Korea), Uram Jin (Ajou Univ., Korea) | ||||
| 10:40-10:49 | Modification of Stress Echocardiography Criteria in HFA-PEFF Algorithm: Based on the Hemodynamic Study | Ji Hyun Cha (Sungkyunkwan Univ., Korea) | ||
| 10:49-10:58 | Respiratory Sarcopenia as a Novel and Powerful Predictor of Mortality in Older Patients Hospitalized for Heart Failure: Findings from the SONIC-HF Study | Taisuke Nakade (Juntendo Univ., Japan) | ||
| 10:58-11:07 | Development of Multimodal Digital Stethoscope System for Self-monitoring of Heart Failure Status | Qun Wei (Keimyung Univ., Korea) | ||
| 11:07-11:16 | Transcriptomic and Network-based Profiling Reveals Key Molecular Pathways and Therapeutic Targets in Dilated Cardiomyopathy | Nadyatul Husna (Reksodiwiryo Military Hospital, Padang, Indonesia) | ||
| 11:16-11:25 | Imagenetics in Non-ischemic Dilated Cardiomyopathy : Linking Cardiac Magnetic Resonance Imaging Phenotypes to Genotypic Signatures | Jooyeon Lee (Yonsei Univ., Korea) | ||
| 11:25-11:34 | Eligibility for FINEARTS-HF in a Real-world Nationwide Cohort with Heart Failure with Mildly Reduced or Preserved Ejection Fraction | Benedikt Beer (Karolinska Institutet, Sweden) | ||
| 11:34-11:43 | Impact of a Discharge Checklist on Guideline-directed Medical Therapy Adherence and Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: A Comparative Observational Study | Eunjoung Choi (Korea Univ., Korea) | ||
| 11:43-11:52 | Modeling HeartBrain Crosstalk in Heart Failure under SGLT2 Inhibition: A Digital Twin Simulation Using Transcriptomics and LigandReceptor Networks | Javad Alizargar (National Taipei Univ., Taiwan) | ||
| 11:52-12:01 | Distinct Inflammasome and Type I Interferon Pathways Drive Divergent Immune Dynamics in Vaccine-associated and Conventional Myocarditis | Yongjae Lee (KAIST, Korea) | ||
Heart Failure Seoul Meets Asia: Korea Training Reflections from Asia
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
| Agora | ||||
| 10:20-11:40 | ENG Heart Failure Seoul Meets Asia: Korea Training Reflections from Asia |
Wook-Jin Chung (Gachon Univ., Korea)
, In-Cheol Kim (Keimyung Univ., Korea) |
||
| Moderator: Chan Joo Lee (Yonsei Univ., Korea) | ||||
| 10:20-10:35 | Heart Failure Management in Indonesia | Olivia Handayani (Mayapada Hospital Kuningan, Indonesia) | ||
| 10:35-10:50 | Enhancing Heart Failure Care in Vietnam | Le Vu Nhu Quynh (Gia Dinh People’s Hospital, Vietnam) | ||
| 10:50-11:05 | Connecting Care Models: Malaysian Perspectives | Goay Swee En (National Heart Institute, Malaysia) | ||
| 11:05-11:20 | Building HF Infrastructure in Cambodia | Socheat Seng (Techo Santepheap National Hospital, Cambodia) | ||
| 11:20-11:40 | Discussion | Anuar Zhunussov (National Scientific Medical Center, Kazakhstan) | ||
[Joint Session with KOSCI] Multimodality Imaging in Heart Failure
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 16:40-18:00 | KOR [Joint Session with KOSCI] Multimodality Imaging in Heart Failure |
Sung Min Ko (Yonsei Wonju Univ., Radiology, Korea)
, Kye Hun Kim (Chonnam National Univ., Korea) |
||
| 심부전 환자 진료에서 CT, MRI 등 다양한 영상 기법의 임상적 활용 및 진단적 가치를 이해하고, AI 기반 분석 도구의 임상/연구 응용 가능성을 탐색한다. | ||||
| 심부전 진단과 치료에 있어 영상의학적 접근이 정밀의료, 조직학적 진단, 예후 예측에 매우 중요한 역할을 하고 있다. 최신 영상 기술과 분석 기법의 역할을 조명하고자 한다. | ||||
| 16:40-16:55 | Precision Medicine with HF Imaging: A Cardiologist's Perspective |
|
Iksung Cho (Yonsei Univ., Korea) | |
| 16:55-17:10 | CT Imaging in Heart Failure |
|
Eun Ju Chun (Seoul National Univ., Radiology, Korea) | |
| 17:10-17:25 | Cardiac MRI in Myocardial Disease: Beyond Late Gadolinium Enhancement |
|
Suyon Chang (The Catholic Univ., Radiology, Korea) | |
| 17:25-17:40 | AI-powered CMR Analysis: Emerging Applications in Heart Failure Imaging |
|
Young Joo Suh (Yonsei Univ., Radiology, Korea) | |
| 17:40-18:00 | Discussion |
Sung Mok Kim (Sungkyunkwan Univ., Radiology, Korea) , Jong-Ho Nam (Yeungnam Univ., Korea) , Sunhwa Lee (Yonsei Univ., Korea) , Sung Ho Hwang (Korea Univ., Radiology, Korea) |
||
HF Seoul Millionaire
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 13:20-14:40 | KOR&ENG HF Seoul Millionaire |
Hyeonju Jeong (Myongji Hospital, Korea)
, Hyukjin Park (Chonnam National Univ., Korea) , Kang-Un Choi (Yeungnam Univ., Korea) , Nuri Lee (Chonnam National Univ., Korea) , Novi Yanti Sari (Siloam Hospitals Lippo Village, Jakarta, Indonesia) |
||
| 본 세션은 참가자들이 심부전 관련 지식을 흥미롭게 학습하고, 글로벌 네트워킹의 기회를 자연스럽게 확장할 수 있도록 기획되었다. ① HFA 수준의 인증 시험에 준하는 퀴즈 문제를 풀며 학문적 성취감을 높이고, ② 국내외 참가자들과의 인터뷰를 통해 다양한 임상 경험과 개인적 동기를 공유하는 기회를 제공한다. |
||||
| Who Wants to be an HFA Millionaire’에서 착안한 본 세션은, 대한심부전학회 참가자들이 보다 능동적으로 참여할 수 있는 기회를 제공하고자 기획되었다. 대부분의 학술세션이 일방향적 강의로 구성되는 현실에서, 본 프로그램은 전문성과 재미를 결합하여 모든 참가자가 자연스럽게 참여하고 교류할 수 있는 유일한 콘텐츠로 자리매김하고자 한다. 현장 퀴즈와 인터랙티브 투표, 인터뷰 등 다양한 구성 요소를 통해 국내외 참석자들이 부담 없이 참여하고 소통하며, 학회의 활기를 더하는 특별 세션이 될 것이다. |
||||
| 13:20-14:40 | HF Seoul Millionaire | |||
Luncheon Session 6 
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room C | ||||
| 12:05-13:00 |
KOR
Luncheon Session 6
|
Il Suk Sohn (Kyung Hee Univ., Korea)
, Hae-Young Lee (Seoul National Univ., Korea) |
||
| 12:05-12:30 | CV Benefits of Dapagliflozin in Heart Failure | Ju-Hee Lee (Chungbuk National Univ., Korea) | ||
| 12:30-13:00 | Hypertension Management with Valsartan & Amlodipine | Min-Seok Kim (Ulsan Univ., Korea) | ||
Moderated Poster 1
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
| Agora | ||||
| 09:00-10:17 | ENG Moderated Poster 1 | Hyun-Jai Cho (Seoul National Univ., Korea) | ||
| 09:00-09:07 | Temporal Trends of Patient Characteristics and Clinical Outcomes in Heart Failure Patients: A Systematic Review and Meta-Regression Analysis | Joon-Seok Kim (The Catholic Univ., Korea) | ||
| 09:07-09:14 | Integrating Epigenetic Enhancer Activity and RNA Translation to Predict Fibrosis Reversibility in Heart Failure: A Deep Learning Approach | Rifaldy Fajar (IMCDS-BRF, Indonesia) | ||
| 09:14-09:21 | Balancing Blood Pressure and Catecholamine Support Is Critical in Cardiogenic Shock Patients | Benedikt Beer (Karolinska Institutet, Sweden) | ||
| 09:21-09:28 | Phenomapping-Derived Tool to Individualize the Effect of Sacubitril/Valsartan in Heart failure with Preserved Ejection Fraction | Minjae Yoon (Seoul National Univ., Korea) | ||
| 09:28-09:35 | Myocardial Tissue Characteristics and Left Ventricular Reverse Remodeling in Non-ischemic Dilated Cardiomyopathy Implemented with Ivabradine | Jooyeon Lee (Yonsei Univ., Korea) | ||
| 09:35-09:42 | Association of Steatotic Liver Disease Subtypes with the Clinical Expression of Hypertrophic Cardiomyopathy: Insights from a Nationwide Cohort Study | Yuran Ahn (The Catholic Univ., Korea) | ||
| 09:42-09:49 | Effects of Guideline-directed Medical Therapy Adherence on Mortality and Fatal Arrhythmias in Ischemic and Non-ischemic Heart Failure with Reduced Ejection Fraction: A National Cohort Analysis | Moojun Kim (Yonsei Univ., Korea) | ||
| 09:49-09:56 | Peak VO₂ as a Predictor of Outcomes in Contemporary Heart Failure Care: Insights From a Multicentre Retrospective Cohort | Natsumi Kashimura (Juntendo Univ., Japan) | ||
| 09:56-10:03 | Impact of ECMO Support on Organ Donation and Transplant Outcomes | Jihyuk Chung (Sungkyunkwan Univ., Korea) | ||
| 10:03-10:10 | Comparing Neighborhood and Individual Socioeconomic Risk Factors in Heart Failure Prognosis: Data from the Swedish Heart Failure Registry | Valente Valeria (Karolinska Institutet, Sweden) | ||
| 10:10-10:17 | The Emerging Miracle Drug in Acute Heart Failure | Farrukh Malik (National Institute of Cardiovascular Diseases, Pakistan) | ||
[Joint Session with NIH] Collaborative Research for Advancing Heart Failure Science
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | KOR [Joint Session with NIH] Collaborative Research for Advancing Heart Failure Science |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Won-Ho Kim (Korea National Institute of Health, Korea) |
||
| 심부전 연구자들이 국가적 연구 자원과 데이터베이스를 이해하고, 인공지능·디지털 헬스·유전체 분석 등 최신 융합기술을 활용한 공동 연구 전략을 수립할 수 있도록 한다. | ||||
| 심부전 연구를 위한 많은 연구 자원과 데이터베이스가 있다는 것은 알고 있지만 구체적으로 어떤 것들이 있고 어떻게 활용할 수 있는지 모르는 경우가 많다. 따라서 막연하게만 알고 있는 연구 자원에 대해서 알아보고 이것을 어떻게 얻고 분석할 수 있을지에 대하여 기초부터 차근차근 알아보는 시간이다. | ||||
| 13:00-13:10 | 어렵지 않아요: 자원 신청부터 활용까지 |
|
Hyun Joung Lim (Korea National Institute of Health, Korea) | |
| 13:10-13:20 | 당신의 연구에 필요한 유전체 · 오믹스 데이터, 우리가 지원합니다 |
|
Sang Cheol Kim (Korea National Institute of Health, Korea) | |
| 13:20-13:30 | 너도 할 수 있어: 국가 자원을 활용한 실제 연구 사례 |
|
Yongho Jee (Ewha Womans Univ., Korea) | |
| 13:30-13:40 | AI와 국가 데이터의 만남: 실전 분석 사례와 가능성 |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 13:40-13:50 | Registry 통합과 미래 활용 전략, Pragmatic RCT로 나아가는 길 |
|
Jong-Chan Youn (The Catholic Univ., Korea) | |
| 13:50-14:20 | Discussion |
Bong-Jo Kim (Korea National Institute of Health, Korea) , Hyo Suk Ahn (The Catholic Univ., Korea) , Ju-Hee Lee (Chungbuk National Univ., Korea) , Jae-Pil Jeon (Korea National Institute of Health, Korea) , Junho Hyun (Ulsan Univ., Korea) |
||
Everyday AI in Healthcare: Real Talk at the AGORA
| Day 3 - Sat, Sep 13 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 15:00-16:20 | KOR Everyday AI in Healthcare: Real Talk at the AGORA |
Dong-Ju Choi (Seoul National Univ., Korea)
, Sunki Lee (Korea Univ., Korea) |
||
| 1) 인공지능(AI)이 실제 의료 현장과 연구 현장에서 어떻게 활용되고 있는지에 대한 구체적인 사례와 경험을 공유한다 2) ChatGPT를 포함한 생성형 AI의 활용 가능성과 한계를 논의하고, 의료 종사자들이 일상 진료 및 학술 활동에 효과적으로 AI를 접목할 수 있는 실질적 방법을 탐색한다. 3) 임상현장에서 사용 가능한 AI 기반 프로그램의 개발과정과 적용 사례를 소개하여, 향후 의료현장에서의 AI 활용 확장 가능성을 제시한다. |
||||
| 최근 ChatGPT와 같은 생성형 인공지능(Generative AI)의 급격한 발전은 의료계 전반에 큰 화두를 던지고 있다. 연구자 입장에서 논문 작성 및 학술활동에서의 AI 활용 사례를 소개, 진료와 연구를 병행하는 의사의 시각에서 생성형 AI(ChatGPT)의 실제 활용 경험과 팁의 공유 그리고 의료 AI 프로그램 개발의 실제적인 여정과 현장 적용 사례를 소개하여 실제 의료진의 다양한 영역에서 AI를 "어떻게" 활용하고 있는지에 대한 현실적인 관점(Real Talk)을 공유하고자 한다. |
||||
| 15:00-15:20 | AI 로 논문쓰기 |
|
Ki-Hyun Jeon (Seoul National Univ., Korea) | |
| 15:20-15:40 | 연구 및 진료에서의 Chat GPT 및 AI의 활용 |
|
Kyoung Min Kim (Yonsei Univ., Endocrinology, Korea) | |
| 15:40-16:00 | AI 기반 임상 현장 적용 프로그램 개발 |
|
Kyung-Hee Kim (Incheon Sejong Hospital, Korea) | |
| 16:00-16:20 | Discussion |
Eui-Soon Kim (The Catholic Univ., Korea) , Bo Eun Park (Kyungpook National Univ., Korea) , Taeil Yang (Gachon Univ., Korea) , Hokyou Lee (Yonsei Univ., Preventive Medicine, Korea) , David Hong (Sungkyunkwan Univ., Korea) |
||
Boot Camp Gosu's Tips: Heart Biopsy & Pericardiocentesis
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 10:30-11:30 | KOR Boot Camp Gosu's Tips: Heart Biopsy & Pericardiocentesis |
Jin-Oh Choi (Sungkyunkwan Univ., Korea)
HOPE Facilitator So Ree Kim (Korea Univ., Korea) |
||
| Panel : Nuri Lee (Chonnam National Univ., Korea), Su Yeon Lee (Dankook Univ., Korea), Jihun Jang (Inha Univ., Korea) | ||||
| 심근 생검의 표준 술기 및 실제 임상에서의 적용 방법을 이해하고 안전성을 높이기 위한 술기적 팁을 습득한다. 고위험 및 복잡한 상황에서의 심낭천자 술기를 숙지하고, 합병증 없이 안전하게 시술하는 노하우를 배운다. | ||||
| 딱딱한 학술대회 강의가 아닌 비교적 자유로운 분위기에서 정보전달 강의가 아닌 청중/패널과 interactive 하게 진행하는 세션으로 강의 중간에 질문과 discussion을 진행을 목표로 한다. 실제 시술 영상을 기반으로, 심근 생검과 심낭천자의 기초 술기부터 고난도 케이스에서의 전략적 접근법까지를 포괄적으로 다루는 세션이다. | ||||
| 10:30-10:45 |
1. Heart Biopsy: Technical Tips with Pre-recorded Video - Heart Biopsy 실제로 하는 Technical Tip, Complication을 피하는 법 |
|
Junho Hyun (Ulsan Univ., Korea) | |
| 10:45-11:00 | Discussion | |||
| 11:00-11:15 |
2. Pericardiocentesis: Tips for Tricky Cases - 어려운 케이스에서 Pericardiocentesis 를 합병증 없이 잘하는 법 |
|
Hyukjin Park (Chonnam National Univ., Korea) | |
| 11:15-11:30 | Discussion | |||
Achieving Survival Benefit in Heart Failure with Beta-Blockers
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room C | ||||
| 14:20-15:30 |
KOR
Achieving Survival Benefit in Heart Failure with Beta-Blockers |
Shung Chull Chae (Kyungpook National Univ., Korea)
, Jin-Yong Hwang (Gyeongsang National Univ., Korea) |
||
| 14:20-14:50 | The Greatest Advantage of Carvedilol and Its Clinical Utility |
|
Jung Hyun Choi (Pusan National Univ., Korea) | |
| 14:50-15:05 | Sharing Real-World Experience I |
|
Hyemoon Chung (Kyung Hee Univ., Korea) | |
| 15:05-15:20 | Sharing Real-World Experience II |
|
Soo Yong Lee (Pusan National Univ., Korea) | |
| 15:20-15:30 | Discussion | Jihun Jang (Inha Univ., Korea) | ||
“의사, 데이터를 들고 밖으로 나가다”
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 13:40-15:00 | KOR “의사, 데이터를 들고 밖으로 나가다” |
Eui-Young Choi (Yonsei Univ., Korea)
HOPE Facilitator Jino Park (Inje Univ., Korea) |
||
| 진료하는 의사가 아닌 창업을 선택한 이유, 그리고 데이터에 주목했던 이유에 대해 들어본다. 환자 진료와 연구, 논문에만 갇혀 있는 청중들의 시각을 좀 더 넓히는 계기를 제공한다. | ||||
| 본 세션은 다른 학술 세션들의 학술적 논의와 연구 발표에서 벗어나 회원들에게 새로운 경험과 시각을 공유하기 위한 교양세션으로 기획되었다. 장기화된 의정사태에서 병원 밖으로의 관심이 높아지고 있는 요즘, 젊은 의사 사장님들에게 창업에 대한 새로운 인사이트를 얻고, AI 시대에서 나만의 전략을 찾은 선생님들의 경험과 비전을 듣고자 한다. | ||||
| 13:40-14:05 | “나는 왜 연구 공장을 세웠는가” | Jeong-Ju Yoo (Soon Chun Hyang Univ., Korea) | ||
| 14:05-14:30 | “Health를 넘어 Wellness로” |
|
Youngin Paul Kim (Gazi Lab, Korea) | |
| 14:30-15:00 | Discussion |
Min Gyu Kong (Soon Chun Hyang Univ., Korea) , Moojun Kim (Yonsei Univ., Korea) , Yoonjee Park (Bucheon Sejong Hospital, Korea) , David Hong (Sungkyunkwan Univ., Korea) |
||
[Advanced Heart Failure Research Working Group] Advancing Heart Transplantation: Can We Do Better?
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Room C Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | KOR [Advanced Heart Failure Research Working Group] Advancing Heart Transplantation: Can We Do Better? |
Seok Min Kang (Yonsei Univ., Korea)
, Jin-Oh Choi (Sungkyunkwan Univ., Korea) |
||
| 심장이식 환자에서 급·아급성 거부반응, 신장기능 악화, 혈관병증(CAV) 등 주요 이식 후 합병증의 조기 진단과 예방 전략을 이해하고, 실제 임상에 적용할 수 있도록 한다. | ||||
| 심장이식 후 생존율 향상과 삶의 질 개선을 위해, 주요 합병증을 예방하기 위한 최신 진단 기법과 예방 전략을 고찰해보고자 한다. | ||||
| 15:40-15:55 | How to Prevent Acute/Subacute Rejection |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:55-16:10 | How to Prevent Biopsy Negative Graft Dysfunction |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 16:10-16:25 | How to Prevent Worsening Renal Function |
|
Jae Yeong Cho (Chonnam National Univ., Korea) | |
| 16:25-16:40 | How to Prevent Coronary Allograft Vasculopathy |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 16:40-17:00 | Discussion |
Jaewon Oh (Yonsei Univ., Korea) , Jong-Chan Youn (The Catholic Univ., Korea) , Hyun-Jai Cho (Seoul National Univ., Korea) , Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
From Blueprint to Bedside: Real-World Lessons in Heart Transplantation
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 15:20-16:40 | KOR From Blueprint to Bedside: Real-World Lessons in Heart Transplantation |
Seok Min Kang (Yonsei Univ., Korea)
, Yang Hyun Cho (Sungkyunkwan Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
| 본 세션은 심장이식 프로그램의 시작부터 실제 진료까지의 전 과정을 이해하고자 하는 의료인을 대상으로 한다. 참가자는 심장이식을 위한 시스템 구축, 교과서적 기준과 실제 임상 간의 차이, 그리고 장기기증 및 이식의 사회적 가치에 대해 통합적으로 학습하게 된다. | ||||
| 딱딱한 학술대회 강의가 아닌 비교적 자유로운 분위기에서 청중/패널과 interactive 하게 진행하는 세션이다. 강의 중간 중간 질문과 discussion을 함께 진행하는 것을 목표로 한다. 각 연자 별 심장이식 프로그램 구축의 실질적 고려사항, 교과서적 기준과 현실의 간극, 심장이식의 공공적 가치를 소개하여 심장이식의 실제를 개인적 경험을 토대로 소개하는 세션이다. | ||||
| 15:20-15:40 | Building a Heart Transplant Program: What You Need to Know (심장이식 프로그램을 어떻게 Set-up 할까) |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 15:40-16:00 | Heart Transplantation: Textbook Criteria vs. Real-World Practice (심장이식 - 교과서에서 현실까지) |
|
Soo Yong Lee (Pusan National Univ., Korea) | |
| 16:00-16:20 | 심장이식, 그 아름다운 가치 |
|
Sujin Oh (KODA, Korea) | |
| 16:20-16:40 | Discussion |
Jino Park (Inje Univ., Korea) , Sang Eun Lee (Ulsan Univ., Korea) , Youngwoo Jang (Gachon Univ., Korea) , Woo Sung Jang (Keimyung Univ., Thoracic and Cardiovascular Surgery, Korea) , In Seok Jeong (Chonnam National Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
Moderated Poster 2
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Agora | ||||
| 09:00-10:10 | ENG Moderated Poster 2 | Sukkeun Hong (Bucheon Sejong Hospital, Korea) | ||
| 09:00-09:07 | Use of ARNI and Risk of Atrial Fibrillation and Ischemic Stroke in Patients with HFrEF: A Nationwide Propensity-matched Cohort Study | Young Jun Park (Yonsei Wonju Univ., Korea) | ||
| 09:07-09:14 | Perceptions and Utilization of Digital Health Technologies among Health Professionals in Korea | Sejun Jeon (ROK Army, Korea) | ||
| 09:14-09:21 | Therapeutic Efficacy and Biomarker-driven Insights of Iron Repletion in Heart Failure: A Comprehensive Meta-analysis | Xuemei Zhao (Fuwai Hospital, CAMS & PUMC, China) | ||
| 09:21-09:28 | Integrative Transcriptomic Approach Identifies Key Pathways and Drug Candidates for Heart Failure | Nadyatul Husna (Reksodiwiryo Military Hospital, Padang, Indonesia) | ||
| 09:28-09:35 | Prognostic Value of QRS Duration in Acute Myocarditis: Insights from a Multicenter Cohort Study | Jihee Son (Sungkyunkwan Univ., Korea) | ||
| 09:35-09:42 | Predicting Prognosis in Heart Failure Using Left Atrial Volume Index: A Marker beyond the Ejection Fraction | Farrukh Malik (National Institute of Cardiovascular Diseases, Pakistan) | ||
| 09:42-09:49 | The Intertwining of Rotating Night Shifts and the Practice of Consuming Light Meals Late at Night Can Heighten the Likelihood of Developing Hypertension, Obesity and Cardiovascular Diseases | Qulsoom Naz (King George's Medical Univ., India) | ||
| 09:49-09:56 | Disease Modeling of FLNC-related Dilated Cardiomyopathy Using hiPSC-derived Cardiac Fibroblasts | Suyeon Jin (Yonsei Univ., Korea) | ||
| 09:56-10:03 | Prognostic Value of Changes in NT-proBNP and sST2 Level in Patients with Chronic Heart Failure and Reduced Ejection Fraction after Undergoing Acute Decompensation during Five Years of Follow-up | Marina Muksinova (National Medical Research Center of Cardiology, Russia) | ||
| 10:03-10:10 | Cardiac Magnetic Resonance Imaging-guided Prediction of Pathogenic Variants in Non-ischemic Dilated Cardiomyopathy | Jooyeon Lee (Yonsei Univ., Korea) | ||
IJHF Session
| Day 1 - Thu, Sep 11 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 16:40-18:00 | KOR IJHF Session |
In-Ho Chae (Seoul National Univ., Korea)
, Jin Joo Park (Seoul National Univ., Korea) |
||
| 본 세션은 편집위원회 구성 세션으로 심부전 연구의 최신 흐름 및 연구 진행에 있어서의 실제적 고려 사항에 대해 논의해 본다. | ||||
| 심부전 연구 분야에 있어서 최신 연구의 동향 및 리뷰어로서 역할, 심부전 연구 성공의 비결에 대해서 토론하는 자리이다. | ||||
| 16:40-16:55 | 심부전 최신 연구 흐름: IJHF 선정 베스트 논문 리뷰 |
|
Dong-Hyuk Cho (Korea Univ., Korea) | |
| 16:55-17:10 | Peer Review (동료평가)에서 필수 요건: 좋은 리뷰어가 되어 보자 |
|
Soo Yong Lee (Pusan National Univ., Korea) | |
| 17:10-17:25 | 표본 크기는 다다익선?: 연구 성공과 실패의 체크 포인트 | Soyeon Ahn (Seoul National Univ., Korea) | ||
| 17:25-17:40 | 심부전 연구의 미래: 어디로 가고 있는가? |
|
Jin Joo Park (Seoul National Univ., Korea) | |
| 17:40-18:00 | Discussion |
Eui-Soon Kim (The Catholic Univ., Korea) , Dae-Hwan Bae (Bucheon Sejong Hospital, Korea) , Minjae Yoon (Seoul National Univ., Korea) , Jihun Jang (Inha Univ., Korea) , Jaehyeong Cho (Keimyung Univ.,, Korea) |
||
HOPE “Interactive Mentor-Mentee Matching Session”
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | KOR HOPE “Interactive Mentor-Mentee Matching Session” |
Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
, Hyung Yoon Kim (Incheon Sejong Hospital, Korea) |
||
| Moderator: Min Sun Kim (Pusan National Univ., Korea) | ||||
| 심부전 분야의 연구 관심사 및 사회적·개인적 경험을 바탕으로 멘토-멘티 간 실질적인 학술적, 인적 교류를 도모한다. 참가자들이 세션 후에도 지속 가능한 관계를 유지하며, 향후 공동 연구나 진로 멘토링으로 이어질 수 있는 기반을 마련한다. | ||||
| 본 세션은 대한심부전학회 회원 간의 학술적 연계뿐 아니라 진로 및 인생 경험을 공유하는 멘토링 기회를 확대하기 위해 기획되었다. 연구 주제 기반의 실시간 멘토-멘티 매칭과 자유로운 소셜 매칭 두 가지 파트로 구성되며, 이를 통해 참가자는 단발성 만남이 아닌 후속 1:1 멘토링 또는 공동 연구 논의로 발전할 수 있는 실질적 출발점을 갖게 된다. | ||||
| 10:40-10:47 | 심장성 쇼크 다기관 연구의 경험 나누기 |
|
Jeong Hoon Yang (Sungkyunkwan Univ., Korea) | |
| 10:47-10:54 | 임상에 기반을 둔 기초 및 유전체 연구, 어떻게 시작할까? |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 10:54-11:00 | 심부전의 강점을 살려 필드를 넘나드는 연구의 기획과 진행 |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 11:00-11:30 | Mentee Match-Up / Round Table Meeting | |||
| 11:30-11:37 | 학회 경험과 네트워킹 팁 |
|
Wook-Jin Chung (Gachon Univ., Korea) | |
| 11:37-11:44 | 해외연수 준비 및 적응 |
|
Jin Joo Park (Seoul National Univ., Korea) | |
| 11:44-11:51 | 일과 가정의 균형 유지 |
|
Jin-Ok Jeong (Chungnam National Univ., Korea) | |
| 11:51-12:00 | Q&A | |||
EuroVision in Heart Failure: Live Talk with the Authors!
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
|
Agora Learning Objective + Session Rationale + |
||||
| 13:00-14:15 | ENG EuroVision in Heart Failure: Live Talk with the Authors! |
Jin-Ok Jeong (Chungnam National Univ., Korea)
, Marco Metra (University of Brescia, Italy) HOPE Facilitator Yoonjee Park (Bucheon Sejong Hospital, Korea) |
||
| Gain insights into the process of planning and executing multicenter registries, and hear the invited speaker share their experiences in clinical practice, research, and their personal life. | ||||
| Join informal and engaging discussions with key representatives of the HFA of the ESC, while gaining valuable insights from experienced senior physicians who have spearheaded pioneering efforts across diverse clinical settings. | ||||
| 13:00-13:10 | Short Introduction and Warm up | |||
| 13:10-13:25 | SWED-HF: How Sweden Assembled a Global Model |
|
Gianluigi Savarese (Karolinska Institutet, Sweden) | |
| 13:25-13:40 | From Idea to Impact: How a Diuretic Trial Made It to NEJM |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 13:40-14:10 | Floor Talk |
Jiwon Seo (Yonsei Univ., Korea) , Sunki Lee (Korea Univ., Korea) |
||
| 14:10-14:15 | Wrap up Talk | |||
Moderated Poster 3
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Agora | ||||
| 14:20-15:02 | ENG Moderated Poster 3 | Sung Kee Ryu (Ewha Womans Univ., Korea) | ||
| 14:20-14:27 | The Role of Multi-parametric Echocardiographic Evaluation at the Outpatient Clinic on Adverse Events in Adult Heart Transplant Patients | Jiwon Park (Keimyung Univ., Korea) | ||
| 14:27-14:34 | Effect of Ivabradine on Heart Failure Patients According to Baseline Serum Natriuretic Peptide Level | Taeil Yang (Gachon Univ., Korea) | ||
| 14:34-14:41 | Implementation and Evaluation of a Social Networking Service-based Mobile Patient-generated Health Data System with Direct Electronic Medical Record Integration: A Prospective Observational Study | Eunjoung Choi (Korea Univ., Korea) | ||
| 14:41-14:48 | Differences in Ischemic Versus Non-ischemic Heart Failure on Guideline Adherence and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from the TRANS-HF Trial | Yinsoo Lee (The Catholic Univ., Korea) | ||
| 14:48-14:55 | An Echocardiography-based Machine Learning Model for Predicting Onset of Heart Failure | Jin Joo Park (Seoul National Univ., Korea) | ||
| 14:55-15:02 | Cancer Risks in Heart Failure Patients: Insights from Ischemic and Non-ischemic Cardiomyopathy | Eun-Young Kim (The Catholic Univ., Korea) | ||
- The Korean Society of Heart Failure
- TEL: +82-2-3275-5335 | FAX: +82-2-3275-5336 | E-Mail: kshf3@kshf.or.kr
- Business Registration No. : 234-82- 63394 | Name of Representative : ByungSu Yoo
